Ex-Sanofi Partnering Chief Wants AI Start-Up Owkin To Be Industry Leader
Alban de La Sablière Has Ambitious Plans
Having led $30bn of acquisitions of companies at Sanofi, the new challenge for its former global head of partnering is to help make Owkin, “the most disruptive AI biotech company in the world,” he tells Scrip.
